Next Generation News and Research

RSS

AI cancer tools may be using visual shortcuts rather than true biology

New research warns that popular deep learning systems trained for cancer pathology may be relying on hidden shortcuts rather than genuine biological signals.

2 Mar 2026

Serial liquid biopsies reveal evolution in advanced prostate cancer

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that androgen receptor (AR) alterations consistently emerged and were linked to poorer outcomes across therapies.

26 Feb 2026

Neem compound gedunin shows promise against pancreatic cancer

Ramadevi Subramani Reddy, Ph.D., remembers the neem tree from her childhood in India - a plant her grandmother used to treat everything from fevers to infections.

26 Feb 2026

HIT cell therapy eradicates solid tumors in preclinical models

CAR T cell therapy has revolutionized the treatment of many blood cancers, but has shown little success against solid tumors, which account for over 85% of all cancers.

26 Feb 2026

Study reveals hidden internal structure within biomolecular condensates

Cells rely on biomolecular condensates to coordinate essential biological processes without surrounding membranes.

25 Feb 2026

Parental obesity before conception raises offspring fatty liver risk

Pre-pregnancy parental overweight and obesity is linked to the next generation's heightened risk of developing fatty liver disease, a potential precursor to cirrhosis and liver failure, suggests research published online in the journal Gut.

24 Feb 2026

Five sessions a day TMS approach may reduce depression symptoms in one week

For the many patients with depression who haven't found relief through medication, transcranial magnetic stimulation (TMS) - a noninvasive therapy that uses magnetic pulses to stimulate specific areas of the brain - has become an increasingly important treatment option.

23 Feb 2026

Review: Natural selection can occur on multiple levels of biological organization

The common view of natural selection is based solely on the individual: A trait allows an organism to out-compete its rivals and is thus passed down to its offspring.

20 Feb 2026

Italian registry sheds light on acute coronary syndromes in women

Preliminary results from an Italian registry describe the risk profile of women experiencing acute coronary syndromes and provide insights to improve management.

19 Feb 2026

AI analyzes ECG to predict ventricular remodeling in patients with repaired tetralogy of Fallot

Researchers at the Mount Sinai Kravis Children's Heart Center led a multicenter effort to develop and validate an artificial intelligence (AI) tool that can analyze a standard electrocardiogram (ECG) to identify patients with repaired tetralogy of Fallot who may be at risk for harmful heart changes typically detected by cardiac MRI.

18 Feb 2026

New technology maps protein production across individual brain cells

The brain's ability to carry out everything from forming memories to coordinating movement depends on its cells producing the right proteins at the right time.

18 Feb 2026

Study reveals previously unknown role for viral protein integrase in HIV's life cycle

The tiny shell protecting the HIV virus resembles a slightly rounded ice cream cone, but there is nothing sweet about it.

18 Feb 2026

Study reveals widespread prenatal exposure of babies to forever chemicals

Babies born between 2003 and 2006 were exposed to many more "forever chemicals" before birth than scientists previously understood, according to new research published in Environmental Science & Technology.

18 Feb 2026

Aptar Pharma’s intranasal solutions power CastleVax Phase II clinical trials for next-gen COVID-19 vaccine

In a significant step forward for mucosal immunity, Aptar Pharma has announced that its innovative nasal delivery systems are being utilized in CastleVax’s Phase II clinical trial for CVAX-01, an intranasal COVID-19 vaccine candidate.

From Hanson Wade Group - 4th Nasal Formulation & Delivery Summit 16 Feb 2026

Adjunctive brexpiprazole boosts schizophrenia patients' information processing speed

Cognitive impairment, including decreased attention and memory, remains one of the most disabling aspects of schizophrenia, affecting social life of patients.

12 Feb 2026

Study uncovers immune trigger behind vaccine-induced immune thrombocytopenia and thrombosis

A global research collaboration of scientists from McMaster University (Canada), Flinders University (Australia) and Universitätsmedizin Greifswald (Germany) uncovered why a small number of people developed dangerous blood clots after either receiving certain COVID‑19 vaccines or experiencing a natural adenovirus infection, and the answer lies in an unexpected case of misdirected targeting by the immune system.

11 Feb 2026

New AI model eliminates false positives in food testing

Researchers have significantly enhanced an artificial intelligence tool used to rapidly detect bacterial contamination in food by eliminating misclassifications of food debris that looks like bacteria.

10 Feb 2026

Early bone molecular changes signal osteoarthritis progression

Osteoarthritis often goes undetected until cartilage damage is advanced, limiting treatment options. A new study shows that molecular changes in subchondral bone occur earlier and can signal disease progression before cartilage loss.

10 Feb 2026

SPT Labtech and Bellbrook Labs introduce high-throughput screening platform for cancer research

SPT Labtech, a global leader in the design and development of automated instrumentation and consumables for life sciences, and BellBrook Labs, a pioneer in high-throughput screening (HTS) assay tools, today announced a collaboration to advance cancer research.

9 Feb 2026

Synthace collaborates with Charles River to offer the global pharma industry more robust, faster and cost-effective assays

Synthace, the leader in software and services for assay development, today announced a collaboration with Charles River Laboratories International, Inc. (Charles River), a leading global drug discovery, development, testing, and manufacturing solutions provider.

9 Feb 2026

Next Generation News and Research

AI cancer tools may be using visual shortcuts rather than true biology

Serial liquid biopsies reveal evolution in advanced prostate cancer

Neem compound gedunin shows promise against pancreatic cancer

HIT cell therapy eradicates solid tumors in preclinical models

Study reveals hidden internal structure within biomolecular condensates

Parental obesity before conception raises offspring fatty liver risk

Five sessions a day TMS approach may reduce depression symptoms in one week

Review: Natural selection can occur on multiple levels of biological organization

Italian registry sheds light on acute coronary syndromes in women

AI analyzes ECG to predict ventricular remodeling in patients with repaired tetralogy of Fallot

New technology maps protein production across individual brain cells

Study reveals previously unknown role for viral protein integrase in HIV's life cycle

Study reveals widespread prenatal exposure of babies to forever chemicals

Aptar Pharma’s intranasal solutions power CastleVax Phase II clinical trials for next-gen COVID-19 vaccine

Adjunctive brexpiprazole boosts schizophrenia patients' information processing speed

Study uncovers immune trigger behind vaccine-induced immune thrombocytopenia and thrombosis

New AI model eliminates false positives in food testing

Early bone molecular changes signal osteoarthritis progression

SPT Labtech and Bellbrook Labs introduce high-throughput screening platform for cancer research

Synthace collaborates with Charles River to offer the global pharma industry more robust, faster and cost-effective assays

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News